Weigao Medical Europe Limited is part of the Shandong Weigao Group Medical Polymer Product Ltd. Company (Shandong Weigao Group) is one of the leading players in the research, development, production and sale of single-use sterilisation medical devices. Founded in 1988, the Weigao Group joined the Hong Kong Stock Exchange of Growth Enterprise Markets in 2004 (8199 HK). The Group has a turnover of 787 million RMB (101 million USD, in 2005-6) and it employs 5,456 people worldwide. Propelled by the government-led nationwide replacement and upgrade cycle, the medical device market is expected to grow at approximately 25% per year until 2010. The Weigao Group not only has the strong manufacturing capability to capitalise on this trend, but also a strong distribution network, making it an attractive partner for companies trying to enter the Chinese market. The company has an extensive customer base of over 5,000 healthcare organisations, including over 2,700 hospitals and 400 blood stations. The company is also actively exploring opportunities in international markets. At present, our products are exported to 30 countries, including the United States, Germany and the United Kingdom. Shandong Weigao Group offers an outstanding range of healthcare products, matched by comprehensive, high quality services. The Group’s success reflects its innovative ability to develop new products, services and systems; often in partnership with hospitals, universities and other specialists. The management systems are certified and comply with standards such as ISO9001, ISO13485, and the CE Mark certificate by TÜV product service.